Hepatitis C Virus Infection and Rheumatic Diseases: The Impact of Direct-Acting Antiviral Agents - Sorbonne Université Access content directly
Journal Articles Rheumatic Disease Clinics of North America Year : 2016

Hepatitis C Virus Infection and Rheumatic Diseases: The Impact of Direct-Acting Antiviral Agents

Abstract

Hepatitis C virus infection is associated with many extrahepatic manifestations, including rheumatic disorders such as arthralgia, myalgia, cryoglobulinemia vasculitis, and sicca syndrome.The treatment of hepatitis C virus infection has long been based on interferon alfa, which was contraindicated in many autoimmune/inflammatory disorders.The emergence of new oral interferon-free combinations now offers an opportunity for patients infected with hepatitis C virus with extrahepatic manifestations, including autoimmune/inflammatory disorders, to be cured with a short treatment duration and a low risk of side effects.
Fichier principal
Vignette du fichier
Cacoub_Hepatitis_C_Virus.pdf (494 Ko) Télécharger le fichier
Origin Files produced by the author(s)
Loading...

Dates and versions

hal-01387968 , version 1 (26-10-2016)

Identifiers

Cite

Patrice Cacoub, Cloé Commarmond, David Sadoun, Anne Claire Desbois. Hepatitis C Virus Infection and Rheumatic Diseases: The Impact of Direct-Acting Antiviral Agents. Rheumatic Disease Clinics of North America, 2016, ⟨10.1016/j.rdc.2016.09.011⟩. ⟨hal-01387968⟩
181 View
396 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More